Project Grant R41GM140787
Award Date
9/20/21
Completion Date
7/19/23
Dollars Obligated
$562K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Indianapolis, IN 46202, USA
Similar Awards
This $255,982 National Science Foundation project grant supports the development of sustainable, cost-effective viral clearance membranes by Filtravate, Inc. to enable efficient monoclonal antibody processing. The NSF Technology, Innovation, and Partnerships program seeks technologies leading to breakthrough solutions for national challenges. Specifically, Filtravate will develop a virus filtration membrane using a synthesis process that is more sustainable and affordable than conventional...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $294,995 to Defined Bioscience Inc. aims to develop a low-cost, plant-based serum replacement for the cultivation of bovine cells used in cell-cultivated meat production. The broader impact of this SBIR Phase I project is to enable more scalable and cost-effective cell expansion for cell-cultivated meat, which offers an alternative to traditional meat sourcing that can reduce...
This $902,504 cooperative agreement from the National Science Foundation Division of Industrial Innovation under the Engineering program (CFDA 47.041) supports the development of a scalable downstream purification process for gene therapy vectors by Isolere Bio, Inc. of Durham, North Carolina. The non-chromatographic method seeks to address current inefficiencies that lead to single digit yields by utilizing a polypeptide-based reagent combining affinity capture with phase separation and...
This $2,996,108 Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program is supporting the development of more efficient cell-free biomanufacturing processes. The project aims to create a robust, reusable platform capable of sustaining multi-enzyme cascades for the efficient synthesis of high-value, enantio-enriched products such as chiral amines and alcohols. This will be achieved by introducing membrane-less...
This $250,000 Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) supports a collaborative research effort to investigate how CO2-H2O mixtures can be used as a tunable media to facilitate the chemical recycling of poly(ethylene) terephthalate (PET) plastics. The project, led by researchers at Northwestern University, the University of Kansas, Washington University in St. Louis, and SLAC National Accelerator Laboratory, aims to (1) elucidate the impact...
This Cooperative Agreement award, funded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, aims to develop a bioprocessing system to isolate and purify therapeutic antibodies directly from cell culture. The $999,998 award to Athem LLC, a minority-owned small business, will enable scaling up a novel nanoparticle-based purification media and an automated prototype system. The goal is to simplify the manufacturing of biologics, reduce...
This $500,000 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences, under the Biological Sciences federal grant program (CFDA 47.074), will support research to develop an end-to-end continuous manufacturing process for cell therapies using robotics and microfluidic technologies. The Georgia Tech Research Corporation will receive funding to create a more integrated workflow based on microfluidic device-enabled genetic engineering, cell expansion, and...
This $650,000 Project Grant awarded by the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program will support the development and testing of a new biomanufacturing process for creating nutraceuticals (plant-based compounds that support human health) and a climate-friendly precipitated calcium carbonate (PCC) product at the University of Maryland Center for Environmental Science (UMCES). The key objectives are to build and test a...
This $568,264 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to develop a scalable bioprocess for manufacturing designer red blood cells (RBCs) derived from induced pluripotent stem cells (iPSCs). The goal is to create a renewable source of RBCs with unique Rh profiles to facilitate the identification of complex Rh antibodies, which is critical for selecting compatible blood donors and...
Media & Process Technology Inc. was awarded a $500,000 Project Grant from the Department of Energy's Advanced Research Projects Agency - Energy (CFDA 81.135) to demonstrate the technical feasibility and energy savings potential of a non-evaporative substrate drying process using supercritical carbon dioxide extraction combined with ceramic membrane ultrafiltration. The two-year award, issued on September 9, 2022, will support development of a process to dewater wet substrates without...